Blog

Rick Admiraal: We developed a comprehensive website with all of our results and the dosing tables for Model-Based ATG dosing

Photo taken from Rick Admiraal/LinkedIn

Apr 21, 2024, 23:20

Rick Admiraal: We developed a comprehensive website with all of our results and the dosing tables for Model-Based ATG dosing

Rick Admiraal, Prinses Máxima Centre for Children, shared a post on LinkedIn:

“Just came back from an inspiring EBMT24 meeting. I presented on our studies in children treated with a bone marrow transplantation. The new model-based dosing of ATG gives an 18% increase in survival chances as compared to standard dosing of ATG. This new dosing helps to improve the outcomes for children with cancer.

The abstract was selected as one of the best abstracts of this meeting. We presented this work earlier this year in the Tandem2024, where it was also selected for the best pediatric abstract session.

We developed a comprehensive website with all of our results and the dosing tables for Model-Based ATG dosing”

Read further.
Source: Rick Admiraal/LinkedIn

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”